Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
Clinical trial NCT07415005 · RECRUITING
Trial details
- NCT number
- NCT07415005
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-24
- Primary completion
- 2028-07-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.